Sign in

CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
901024039
Phone
203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
  1. 10-K Report Annual Report
  2. 8-K Event Results of operations
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 424B5 Offering Prospectus
  13. EFFECT Other Notice of Effectiveness
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. UPLOAD Other SEC-generated Letter
  16. S-3 Offering Registration Statement
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 8-K Event Other events
  19. SC 13D Stake Beneficial Ownership Report
  20. 10-Q Report Quarterly Report

Page 7 of 24 · 467 filings